Form D · Biotechnology
InDevR, Inc.
Boulder, CO · CIK 0001787617
Offering snapshot reported Jan 18, 2023 · SEC filing
- Reported sold
- $6M Offering amount: $9M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 24, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 18, 2023 | Initial | $5,999,975 | No comparison | 3 | SEC filing |
| Sep 10, 2019 | Initial | $3,999,998 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-471020
Source: Form D, filed Jan 18, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Chang | Director |
| Erica Dawson | Executive |
| Laura Kuck | Executive |
| Michael Reynier | Director |
| Glenn Rockman | Director |
| Shannon Rodriguez | Director, Executive, Promoter |
| Kathy Rowlen | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2100 Central Avenue Suite 105
Boulder, CO, 80301
Boulder, CO, 80301